USFDA completes inspection of Natco Pharma’s API Facility

17 Feb 2018 Evaluate

United States Food and Drug Administration (USFDA) has successfully completed regulatory inspection of Natco Pharma’s Active Pharmaceutical Ingredient (API) facility in Mekaguda Village, Hyderabad.

The inspection was conducted during the period February 12-16, 2018. The regulatory audit resulted in zero observations.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.


Natco Pharma Share Price

948.50 -9.00 (-0.94%)
19-Mar-2026 12:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1760.10
Dr. Reddys Lab 1274.70
Cipla 1248.70
Zydus Lifesciences 884.65
Lupin 2264.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×